Resveratrol: A polyphenol for all seasons

Resveratrol in Health and Disease

Volumn , Issue , 2005, Pages 1-16

  Shishodia, Shishir ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055475696     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420026474     Document Type: Chapter

References (31)

1. Heber D, Vegetables, fruits and phytoestrogens in the prevention of diseases, J Postgrad Med 50, 145-149, 2004.
2. Paul B, Masih I, Deopujari J, and Charpentier C, Occurrence of resveratrol and pterostilbene in age-old darakchasava, an Ayurvedic medicine from India, J Ethnopharmacol 68, 71-76, 1999.
3. Takaoka MJ, J Faculty Sci Hokkaido Imperial Univ 3, 1-16, 1940.
4. Vastano BC, Chen Y, Zhu N, Ho CT, Zhou Z, and Rosen RT, Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum, J Agric Food Chem 48, 253-256, 2000.
5. Lee SK, Mbwambo ZH, Chung H, Luyengi L, Gamez EJ, Mehta RG, Kinghorn AD, and Pezzuto JM, Evaluation of the antioxidant potential of natural products, Comb. Chem. High Throughput Screen 1, 35-46, 1998.
6. Cichewicz RH and Kouzi SA, Resveratrol oligomers: structure, chemistry, and biological activity, J Nat. Prod. Chem 26, 507-579, 2002.
7. Langcake P and Pryce RJ, The production of resveratrol by Vitis vinifera and other members of the Vitaseae as a response to infection or injury, Physiol Plant Pathol 9, 77-86, 1976.
8. Langcake P and McCarthy W, The relationship of resveratrol production to infection of grapevine leaves by Botrytis cinerea, Vitis 18, 244-253, 1979.
9. Creasy LL and Coffee M, Phytoalexin production potential of grape berries, J Am Soc Hortic Sci 113, 230-234, 1988.
10. Kopp P, Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the “French paradox’'?, Eur J Endocrinol 138, 619-620, 1998.
11. Sun AY, Simonyi A, and Sun GY, The “French Paradox” and beyond:neuroprotective effects of polyphenols, Free Radical Biol Med 32, 314-318, 2002.
12. Levenson AS, Svoboda KM, Pease KM, Kaiser SA, Chen B, Simons LA, Jovanovic BD, Dyck PA, and Jordan VC, Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor, Cancer Res 62, 4419-4426, 2002.
13. Narayanan BA, Narayanan NK, Re GG, and Nixon DW, Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets, Int J Cancer 104, 204-212, 2003.
14. Yang SH, Kim JS, Oh TJ, Kim MS, Lee SW, Woo SK, Cho HS, Choi YH, Kim YH, Rha SY, Chung HC, and An SW, Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray, Int J Oncol 22, 741-750, 2003.
15. Shi T, Liou LS, Sadhukhan P, Duan ZH, Novick AC, Hissong JG, Almasan A, and DiDonato JA, Effects of resveratrol on gene expression in renal cell carcinoma, Cancer Biol Ther 3, 2004.
16. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, and Dannenberg AJ, Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells, J Biol Chem 273, 21875-21882, 1998.
17. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T, and Jager W, Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship, Bioorg Med Chem 12, 5571-5578, 2004.
18. Opipari AW, Jr, Tan L, Boitano AE, Sorenson DR, Aurora A, and Liu JR, Resveratrol-induced autophagocytosis in ovarian cancer cells, Cancer Res 64, 696-703, 2004.
19. Wu SL, Sun ZJ, Yu L, Meng KW, Qin XL, and Pan CE, Effect of resveratrol and in combination with 5-FU on murine liver cancer, World J Gastroenterol 10, 3048-3052, 2004.
20. Olas B, Nowak P, and Wachowicz B, Resveratrol protects against peroxynitrite- induced thiol oxidation in blood platelets, Cell Mol Biol Lett 9, 577-587, 2004.
21. Baatout S, Derradji H, Jacquet P, Ooms D, Michaux A, and Mergeay M, Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol, Int J Mol Med 13, 895-902, 2004.
22. Zoberi I, Bradbury CM, Curry HA, Bisht KS, Goswami PC, Roti Roti JL, and Gius D, Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines, Cancer Lett 175, 165-173, 2002.
23. Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, and DeLucia AL, Resveratrol inhibition of herpes simplex virus replication, Antiviral Res 43, 145-155, 1999.
24. Docherty JJ, Smith JS, Fu MM, Stoner T, and Booth T, Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice, Antiviral Res 61, 19-26, 2004.
25. Walle T, Hsieh F, DeLegge MH, Oatis JE, Jr, and Walle UK, High absorption but very low bioavailability of oral resveratrol in humans, Drug Metab Dispos 32, 1377-1382, 2004.
26. Pisters KM, Newman RA, Coldman B, Shin DM, Khuri FR, Hong WK, Glisson BS, and Lee JS, Phase I trial of oral green tea extract in adult patients with solid tumors, J Clin Oncol 19, 1830-1838, 2001.
27. Omenn GS, Chemoprevention of lung cancer: the rise and demise of beta-carotene, Annu Rev Public Health 19, 73-99, 1998.
28. Cohn W, Thurmann P, Tenter U, Aebischer C, Schierle J, and Schalch W, Comparative multiple dose plasma kinetics of lycopene administered in tomato juice, tomato soup or lycopene tablets, Eur J Nutr 43, 304-312, 2004.
29. Szewczuk LM, Forti L, Stivala LA, and Penning TM, Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents, J Biol Chem 279, 22727-22737, 2004.
30. Diwadkar-Navsariwala V, Novotny JA, Gustin DM, Sosman JA, Rodvold KA, Crowell JA, Stacewicz-Sapuntzakis M, and Bowen PE, A physiological pharmacokinetic model describing the disposition of lycopene in healthy men, J Lipid Res 44, 1927-1939, 2003.
31. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, and Takada Y, Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res 24, 2783-2840, 2004.